Certain SGLT2 inhibitors, GLP-1 RAs for T2DM also cut CV risk 11-30-2018 mediabest Health Problems (HealthDay)—Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 Read more